Childhood cancer survival in France, 1990-1999

European Journal of Cancer

Volumn 44, Issue 2, 2008, Pages 205-215

  Desandes, Emmanuel ^a   Berger, Claire ^b   Tron, Isabelle ^c   Demeocq, François ^d   Bellec, Stéphanie ^e,f,g,h   Blouin, Pascale ^d   Casagranda, Léonie ^b   De Lumley, Lionel ^d   Freycon, Fernand ^b   Goubin, Aurélie ^e,f,g,h   Le Gall, Edouard ^c   Sommelet, Danièle ^a   Lacour, Brigitte ^a   Clavel, Jacqueline ^e,f,g,h  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Childhood Cancer Registry of the Rhône Alpes Region   (France)

^c Childhood Cancer Registry of Bretagne   (France)

^d Childhood Cancer Registry of Auvergne/Limousin   (France)

^e French National Registry of Childhood Blood Malignancies RNHE   (France)

^f Childhood Cancer Regis Val de Marne   (France)

^g INSERM   (France)

^h UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Cancer; Children; Population based study; Prognosis; Registry; Survival

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; AGE DISTRIBUTION; ARTICLE; ASTROCYTOMA; B CELL LEUKEMIA; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER REGISTRY; CANCER RELAPSE; CANCER SURVIVAL; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHILDHOOD MORTALITY; EPENDYMOMA; EWING SARCOMA; FRANCE; GERM CELL TUMOR; GLIOMA; HEPATOBLASTOMA; HUMAN; INTRACRANIAL TUMOR; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; NEPHROBLASTOMA; NERVE TUMOR; NEUROBLASTOMA; NEUROECTODERM TUMOR; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVERALL SURVIVAL; POPULATION RESEARCH; PRE B CELL LEUKEMIA; PRIORITY JOURNAL; RETINOBLASTOMA; RHABDOMYOSARCOMA; RISK REDUCTION; SECOND CANCER; SEX DIFFERENCE; SOFT TISSUE SARCOMA; SPINAL CORD TUMOR; SURVIVAL RATE; SURVIVAL TIME; T CELL LEUKEMIA; THYROID CARCINOMA;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; FEMALE; FRANCE; HUMANS; INFANT; MALE; MORTALITY; NEOPLASMS;

EID: 38349053143     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.11.016     Document Type: Article

References (58)

1. Desandes E., Clavel J., Berger C., et al. Cancer incidence among children in France, 1990-1999. Pediatr Blood Cancer 43 (2004) 749-757
2. Haut comité de la santé publique. La santé en France 2002. Paris: Ecole Nationale de Santé Publique (ENSP); 2002.
3. Parkin DM, Kramarova E. Materials and methods. In: Parkin DM, Kramarova E, Draper GJ, et al., editors. International incidence of childhood cancer, vol. II. Lyon: IARC Scientific Publications No 144; 1998. p. 3-14 [chapter 2].
4. Fritz A., Percy C., Jack A., et al. International classification of diseases for oncology. 3rd ed. (2000), World Health Organization, Geneva
5. Steliarova-Foucher E., Stiller C., Lacour B., and Kaatsch P. International classification of childhood cancer, 3rd ed. Cancer 103 (2005) 1457-1467
6. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. World health classification of tumours. Pathology & genetics. Tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon
7. Shuster J.J. Median follow-up in clinical trials. J Clin Oncol 9 (1991) 191-192
8. Kaplan E., and Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
9. Mantel N. Evaluation of survival date and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
10. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient II. analysis and examples. Br J Cancer 35 (1977) 1-39
11. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER cancer, 1975-2000 statistics review vol. 2007 (2003), National Cancer Institute, Bethesda (MD).
12. Cox D.R., and Oakes D. Analysis of survival data (1990), Chapman and Hall, New York
13. Gatta G., Corazziari I., Magnani C., Peris-Bonet R., Roazzi P., and Stiller C. Childhood cancer survival in Europe. Ann Oncol 14 Suppl. 5 (2003) v119-v127
14. Berrino F., Gatta G., Sant M., and Capocaccia R. The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer 37 (2001) 673-677
15. Clavel J., Steliarova-Foucher E., Berger C., Danon S., and Valerianova Z. Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project. Eur J Cancer 42 (2006) 2037-2049
16. Coebergh J.W., Reedijk A.M., de Vries E., et al. Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2019-2036
17. Izarzugaza M.I., Steliarova-Foucher E., Carmen Martos M., and Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2050-2063
18. MacCarthy A., Draper G.J., Steliarova-Foucher E., and Kingston J.E. Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2092-2102
19. Pastore G., Peris-Bonet R., Carli M., Martinez-Garcia C., de Toledo J.S., and Steliarova-Foucher E. Childhood soft tissue sarcomas incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2136-2149
20. Pastore G., Znaor A., Spreafico F., Graf N., Pritchard-Jones K., and Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2103-2114
21. Peris-Bonet R., Martinez-Garcia C., Lacour B., et al. Childhood central nervous system tumours - incidence and survival in Europe (1978-1997): Report from Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2064-2080
22. Sankila R., Martos Jimenez M.C., Miljus D., Pritchard-Jones K., Steliarova-Foucher E., and Stiller C. Geographical comparison of cancer survival in European children (1988-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 1972-1980
23. Spix C., Pastore G., Sankila R., Stiller C.A., and Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2081-2091
24. Steliarova-Foucher E., Stiller C.A., Pukkala E., Lacour B., Plesko I., and Parkin D.M. Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2150-2169
25. Stiller C.A., Bielack S.S., Jundt G., and Steliarova-Foucher E. Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2124-2135
26. Stiller C.A., Pritchard J., and Steliarova-Foucher E. Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42 (2006) 2115-2123
27. Goubin A., Auclerc M.F., Auvrignon A., et al. Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000). Eur J Cancer 42 (2006) 534-541
28. Aronson D.C., Schnater J.M., Staalman C.R., et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23 (2005) 1245-1252
29. Brown J., Perilongo G., Shafford E., et al. Pretreatment prognostic factors for children with hepatoblastoma - results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36 (2000) 1418-1425
30. Ortega J.A., Douglass E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 (2000) 2665-2675
31. von Schweinitz D. Identification of risk groups in hepatoblastoma - another step in optimising therapy. Eur J Cancer 36 (2000) 1343-1346
32. Schnater J.M., Aronson D.C., Plaschkes J., et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94 (2002) 1111-1120
33. Viscomi S., Pastore G., Mosso M.L., et al. Population-based survival after childhood cancer diagnosed during 1970-98: a report from the Childhood Cancer Registry of Piedmont, Italy. Haematologica 88 (2003) 974-982
34. Ries L.A.G., Harkins D., Krapcho M., et al. SEER cancer, 1975-2003 statistics review vol. 2007 (2006), National Cancer Institute, Bethesda (MD).
35. Pastore G., Viscomi S., Gerov G.L., Terracini B., Madon E., and Magnani C. Population-based survival after childhood lymphoblastic leukaemia in time periods corresponding to specific clinical trials from 1979 to 1998-a report from the Childhood Cancer Registry of Piedmont (Italy). Eur J Cancer 39 (2003) 952-960
36. Schaison G., Auclerc M.F., Baruchel A., Leblanc T., and Leverger G. Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93. Bull Acad Natl Med 185 (2001) 149-160
37. Strother D., Pollack I.F., Fisher P.G., et al. Tumors of central nervous system. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology (2002), Lippincott, Philadelphia 751-824
38. Sauvat F., Sarnacki S., Brisse H., et al. Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter study. Cancer 94 (2002) 2474-2480
39. Brunning R.D., Borowitz M., Matutes E., et al. Precursor B lymphoblastic leukaemia/lymphoblastic lymphoma (precursor B-cell acute lymphoblastic leukaemia). In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). World health classification of tumours. Pathology & genetics. Tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 111-114
40. Magnani C., Pastore G., Coebergh J.W., Viscomi S., Spix C., and Steliarova-Foucher E. Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer 42 (2006) 1981-2005
41. Pui C.H. Childhood leukemias. N Engl J Med 332 (1995) 1618-1630
42. Pui C.H., Campana D., and Evans W.E. Childhood acute lymphoblastic leukaemia - current status and future perspectives. Lancet Oncol 2 (2001) 597-607
43. Wells R.J., Woods W.G., Lampkin B.C., et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group. J Clin Oncol 11 (1993) 538-545
44. Woods W.G., Kobrinsky N., Buckley J.D., et al. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood 87 (1996) 4979-4989
45. Stevens R.F., Hann I.M., Wheatley K., and Gray R.G. Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party. Br J Haematol 101 (1998) 130-140
46. Perel Y., Auvrignon A., Leblanc T., et al. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit - multicenter studies of the French LAME (Leucemie Aigue Myeloblastique Enfant) Cooperative Group. Leukemia 19 (2005) 2082-2089
47. Hann I.M., Webb D.K., Gibson B.E., and Harrison C.J. MRC trials in childhood acute myeloid leukaemia. Ann Hematol 83 Suppl. 1 (2004) S108-S112
48. Hamre M.R., Williams J., Chuba P., Bhambhani K., Ravindranath Y., and Severson R.K. Early deaths in childhood cancer. Med Pediatr Oncol 34 (2000) 343-347
49. Riley L.C., Hann I.M., Wheatley K., and Stevens R.F. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party. Br J Haematol 106 (1999) 436-444
50. Rodriguez-Galindo C., Spunt S.L., and Pappo A.S. Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol 40 (2003) 276-287
51. Pinkerton C.R., Bataillard A., Guillo S., Oberlin O., Fervers B., and Philip T. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 37 (2001) 1338-1344
52. Prete A., Rosito P., Alvisi P., et al. G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood. Bone Marrow Transplant 22 Suppl. 5 (1998) S21-S23
53. Horowitz M.E., Kinsella T.J., Wexler L.H., et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11 (1993) 1911-1918
54. Hartmann O., Oberlin O., Beaujean F., et al. Role of high-dose chemotherapy followed by bone marrow autograft in the treatment of metastatic Ewing's sarcoma in children. Bull Cancer 77 (1990) 181-187
55. Ladenstein R., Lasset C., Pinkerton R., et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry. Bone Marrow Transplant 15 (1995) 697-705
56. Miser J.S., Kinsella T.J., Triche T.J., et al. Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: six months of intensive combined modality therapy without maintenance. J Clin Oncol 6 (1988) 484-490
57. Atra A., Whelan J.S., Calvagna V., et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant 20 (1997) 843-846
58. Burdach S., Jurgens H., Peters C., et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 11 (1993) 1482-1488